Novormon 5000 5000 Unit (Gonadotrophin Serum (Pmsg) POWDER FOR SOLUTION) 5000 UNIT

NOVORMON 5000 is a gonadotrophin serum (PMSG) powder for solution, used for reproductive health support. This 5000 unit strength product is administered intramuscularly and comes in a 25ml pack size.

Strength

5000 UNIT

Pack Size

25ML

Manufacturer / TM Owner

SYNTEX S.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NOVORMON 5000 is primarily used to support reproductive health in both veterinary and human applications. Gonadotrophin serum (PMSG) is often utilized to stimulate follicle development and ovulation. This medication is commonly sought after for its role in reproductive therapies, making it a key component in fertility treatments.

Side Effects

When administered as directed, NOVORMON 5000 may help stimulate the ovaries to produce follicles. Users may experience varied responses based on individual health conditions. It is important to monitor for any unusual effects and consult with a healthcare provider if concerns arise.

Precautions & Warnings

NOVORMON 5000 should be handled with care, ensuring proper storage and preparation. It is crucial to follow the recommended guidelines for intramuscular administration. Users should be aware of potential allergic reactions and discontinue use if severe side effects occur.

Avoid Interactions

NOVORMON 5000 may interact with other medications, particularly those affecting hormone levels. It is advisable to inform healthcare providers of all current medications to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of gonadotrophin serum (PMSG).

Frequently Asked Questions

NOVORMON 5000 is used to support reproductive health by stimulating follicle development and ovulation.

NOVORMON 5000 is administered intramuscularly after being prepared as a solution.

Common effects include stimulation of the ovaries to produce follicles, which may vary based on individual health conditions.

Yes, it is important to handle NOVORMON 5000 with care, follow administration guidelines, and monitor for any unusual effects.

Yes, NOVORMON 5000 may interact with medications affecting hormone levels, so it is advisable to inform healthcare providers of all current medications.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.